Product NDC: | 44567-510 |
Proprietary Name: | CISplatin |
Non Proprietary Name: | CISplatin |
Active Ingredient(s): | 1 mg/mL & nbsp; CISplatin |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 44567-510 |
Labeler Name: | WG Critical Care, LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA018057 |
Marketing Category: | NDA |
Start Marketing Date: | 20120113 |
Package NDC: | 44567-510-01 |
Package Description: | 1 VIAL, MULTI-DOSE in 1 CARTON (44567-510-01) > 100 mL in 1 VIAL, MULTI-DOSE |
NDC Code | 44567-510-01 |
Proprietary Name | CISplatin |
Package Description | 1 VIAL, MULTI-DOSE in 1 CARTON (44567-510-01) > 100 mL in 1 VIAL, MULTI-DOSE |
Product NDC | 44567-510 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | CISplatin |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20120113 |
Marketing Category Name | NDA |
Labeler Name | WG Critical Care, LLC |
Substance Name | CISPLATIN |
Strength Number | 1 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Platinum-based Drug [EPC],Platinum-containing Compounds [Chemical/Ingredient] |